<VariationArchive VariationID="550635" VariationName="NM_005562.3(LAMC2):c.1782_1783del (p.Lys594fs)" VariationType="Deletion" Accession="VCV000550635" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2018-08-05" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="540748" VariationID="550635">
      <GeneList>
        <Gene Symbol="LAMC2" FullName="laminin subunit gamma 2" GeneID="3918" HGNC_ID="HGNC:6493" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="183186264" stop="183258968" display_start="183186264" display_stop="183258968" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="183155173" stop="183214261" display_start="183155173" display_stop="183214261" Strand="+" />
          </Location>
          <OMIM>150292</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005562.3(LAMC2):c.1782_1783del (p.Lys594fs)</Name>
      <CanonicalSPDI>NC_000001.11:183231027:GC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="183231028" stop="183231029" display_start="183231028" display_stop="183231029" variantLength="2" positionVCF="183231027" referenceAlleleVCF="AGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="183200163" stop="183200164" display_start="183200163" display_stop="183200164" variantLength="2" positionVCF="183200162" referenceAlleleVCF="AGC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>K594fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.183200163_183200164del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.183200163_183200164del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.183231028_183231029del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.183231028_183231029del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007079.2" sequenceAccession="NG_007079" sequenceVersion="2" change="g.49765_49766del">
            <Expression>NG_007079.2:g.49765_49766del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005562.3" sequenceAccession="NM_005562" sequenceVersion="3" change="c.1782_1783del" MANESelect="true">
            <Expression>NM_005562.3:c.1782_1783del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005553.2" sequenceAccession="NP_005553" sequenceVersion="2" change="p.Lys594fs">
            <Expression>NP_005553.2:p.Lys594fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018891.3" sequenceAccession="NM_018891" sequenceVersion="3" change="c.1782_1783del">
            <Expression>NM_018891.3:c.1782_1783del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061486.2" sequenceAccession="NP_061486" sequenceVersion="2" change="p.Lys594fs">
            <Expression>NP_061486.2:p.Lys594fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1553266871" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005562.3(LAMC2):c.1782_1783del (p.Lys594fs) AND Junctional epidermolysis bullosa gravis of Herlitz" Accession="RCV000665428" Version="1">
        <ClassifiedConditionList TraitSetID="2421">
          <ClassifiedCondition DB="MedGen" ID="C0079683">Junctional epidermolysis bullosa gravis of Herlitz</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005562.3(LAMC2):c.1782_1783del (p.Lys594fs) AND Junctional epidermolysis bullosa" Accession="RCV001280655" Version="1">
        <ClassifiedConditionList TraitSetID="13197">
          <ClassifiedCondition DB="MedGen" ID="C0079301">Junctional epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005562.3(LAMC2):c.1782_1783del (p.Lys594fs) AND not provided" Accession="RCV001855441" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-23" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-08-05" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11907499</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15373767</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17916201</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31395954</ID>
        </Citation>
        <DescriptionHistory Dated="2021-01-05">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2421" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5022" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa gravis of Herlitz</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Letalis/2580" DB="Genetic Alliance" />
                <XRef ID="400140006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, Herlitz-Pearson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-Pearson type epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Letalis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-type junctional epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JEB-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0007" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2153" />
                <XRef ID="2153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <XRef ID="79404" DB="Orphanet" />
              <XRef ID="C0079683" DB="MedGen" />
              <XRef ID="MONDO:0009182" DB="MONDO" />
              <XRef Type="MIM" ID="226700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9513" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0017612" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2152" />
                <XRef ID="2152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="305" DB="Orphanet" />
              <XRef ID="C0079301" DB="MedGen" />
              <XRef ID="MONDO:0017612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS226650" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1539853" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="23719|OMIM:226700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000789549" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15373767</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="A" referenceAllele="AGC" start="183200162" stop="183200164" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005562.2:c.1782_1783delGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2892635" SubmissionDate="2020-12-31" DateLastUpdated="2021-01-07" DateCreated="2021-01-07">
        <ClinVarSubmissionID localKey="NM_005562.2:c.1782_1783delGC|MedGen:C0079301" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001467936" DateUpdated="2021-01-07" DateCreated="2021-01-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15373767</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17916201</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31395954</ID>
          </Citation>
          <Comment>Variant summary: LAMC2 c.1782_1783delGC (p.Lys594AsnfsX9) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251460 control chromosomes. c.1782_1783delGC has been reported in the literature in individuals affected with Junctional Epidermolysis Bullosa (example, Posteraro_2004, Castori_2008, Wojcik_2019). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on hemidesmosome-anchoring filament complexes (Castori_2008). The most pronounced variant effect results in complete absence of hemidesmosome staining by transmission electron microscopy of the basement membrane zone. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005562.2:c.1782_1783delGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Junctional epidermolysis bullosa</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0079301" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8831147</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4140560" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4822031|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002119751" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15373767</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31395954</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11907499</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 550635). This variant is also known as 1899delGC. This premature translational stop signal has been observed in individual(s) with clinical features of LAMC2-related conditions (PMID: 15373767, 31395954). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys594Asnfs*9) in the LAMC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMC2 are known to be pathogenic (PMID: 11907499, 16473856).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.183200163_183200164del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2892635" TraitType="Disease" MappingType="Name" MappingValue="Junctional epidermolysis bullosa" MappingRef="Preferred">
        <MedGen CUI="C0079301" Name="Junctional epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1539853" TraitType="Disease" MappingType="XRef" MappingValue="226700" MappingRef="OMIM">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4140560" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

